GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » The Calmer Co International Ltd (ASX:CCO) » Definitions » Valuation Rank

The Calmer Co International (ASX:CCO) Valuation Rank


View and export this data going back to 2018. Start your Free Trial

What is The Calmer Co International Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


The Calmer Co International Valuation Rank Related Terms

Thank you for viewing the detailed overview of The Calmer Co International's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


The Calmer Co International Business Description

Traded in Other Exchanges
N/A
Address
96 Victoria Street, West End, Brisbane, QLD, AUS, 4101
The Calmer Co International Ltd is mainly engaged in the research, development, and selling of kava extracts as a consumer product. Its business objective is the primary production of kava through a network of outsourced kava farms and via its Farm located in Fiji and the production and sale of kava supplements and complementary medicines. The company has produced three types of products in the market: shots, powders, and capsules. Its reportable segments are; Fiji Kava Australia Trading Pty Ltd (Fiji Kava Australia Trading) which derives maximum revenue, South Pacific Elixirs Pty Limited (SPE Fiji), Fiji Kava Inc (USA), and Danodan Hempworks LLC (USA). Geographically, it derives key revenue from Australia and the rest from Fiji, and other regions.